Literature DB >> 17276197

Impaired wound healing.

Nathan B Menke1, Kevin R Ward, Tarynn M Witten, Danail G Bonchev, Robert F Diegelmann.   

Abstract

Nonhealing wounds represent a significant cause of morbidity and mortality for a large portion of the population. One of the underlying mechanisms responsible for the failure of chronic wounds to heal is an out-of-control inflammatory response that is self-sustaining. Underappreciation of the inherent complexity of the healing wound has led to the failure of monotherapies, with no significant reduction in wound healing times. A model of the inflammatory profile of a nonhealing wound is one in which the equilibrium between synthesis and degradation has been shifted toward degradation. This review summarizes the current information regarding acute wound healing responses as contrasted to the delayed response characteristic of chronic wounds. In addition, some initial complexity theoretical models are proposed to define and explain the underlying pathophysiology.

Mesh:

Year:  2007        PMID: 17276197     DOI: 10.1016/j.clindermatol.2006.12.005

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  154 in total

1.  A mathematical model for chronic wounds.

Authors:  Avner Friedman; Chuan Xue
Journal:  Math Biosci Eng       Date:  2011-04       Impact factor: 2.080

2.  [Cutaneous wound healing. Therapeutic interventions].

Authors:  J Heinlin; S Schreml; P Babilas; M Landthaler; S Karrer
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

Review 3.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 4.  Chemokines as Therapeutic Targets to Improve Healing Efficiency of Chronic Wounds.

Authors:  Latha Satish
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 5.  Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds.

Authors:  Giovanni Marfia; Stefania Elena Navone; Clara Di Vito; Nicola Ughi; Silvia Tabano; Monica Miozzo; Carlo Tremolada; Gianni Bolla; Chiara Crotti; Francesca Ingegnoli; Paolo Rampini; Laura Riboni; Roberta Gualtierotti; Rolando Campanella
Journal:  Organogenesis       Date:  2015       Impact factor: 2.500

6.  Adipose-derived mesenchymal stem cells accelerate diabetic wound healing in a similar fashion as bone marrow-derived cells.

Authors:  Jianming Guo; Haidi Hu; Jolanta Gorecka; Hualong Bai; Hao He; Roland Assi; Toshihiko Isaji; Tun Wang; Ocean Setia; Lara Lopes; Yongquan Gu; Alan Dardik
Journal:  Am J Physiol Cell Physiol       Date:  2018-11-07       Impact factor: 4.249

7.  Nanofiber-expanded human umbilical cord blood-derived CD34+ cell therapy accelerates murine cutaneous wound closure by attenuating pro-inflammatory factors and secreting IL-10.

Authors:  Suman Kanji; Manjusri Das; Reeva Aggarwal; Jingwei Lu; Matthew Joseph; Sujit Basu; Vincent J Pompili; Hiranmoy Das
Journal:  Stem Cell Res       Date:  2013-11-15       Impact factor: 2.020

Review 8.  Activity of mesenchymal stem cells in therapies for chronic skin wound healing.

Authors:  Austin Nuschke
Journal:  Organogenesis       Date:  2013-12-10       Impact factor: 2.500

9.  Pseudomonas aeruginosa uses T3SS to inhibit diabetic wound healing.

Authors:  Josef Goldufsky; Stephen J Wood; Vijayakumar Jayaraman; Omar Majdobeh; Lin Chen; Shanshan Qin; Chunxiang Zhang; Luisa A DiPietro; Sasha H Shafikhani
Journal:  Wound Repair Regen       Date:  2015-07-27       Impact factor: 3.617

10.  Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury.

Authors:  Thomas A Davis; Alexander Stojadinovic; Khairul Anam; Mihret Amare; Shruti Naik; George E Peoples; Douglas Tadaki; Eric A Elster
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.